Meshinchi S - Search Results

1

Genetic mechanisms of primary chemotherapy resistance in pediatric acute myeloid leukemia.

McNeer NA, Philip J, Geiger H, Ries RE, Lavallée VP, Walsh M, Shah M, Arora K, Emde AK, Robine N, Alonzo TA, Kolb EA, Gamis AS, Smith M, Gerhard DS, Guidry-Auvil J, Meshinchi S, Kentsis A. McNeer NA, et al. Among authors: meshinchi s. Leukemia. 2019 Aug;33(8):1934-1943. doi: 10.1038/s41375-019-0402-3. Epub 2019 Feb 13. Leukemia. 2019. PMID: 30760869 Free PMC article.

2

Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia.

Meshinchi S, Woods WG, Stirewalt DL, Sweetser DA, Buckley JD, Tjoa TK, Bernstein ID, Radich JP. Meshinchi S, et al. Blood. 2001 Jan 1;97(1):89-94. doi: 10.1182/blood.v97.1.89. Blood. 2001. PMID: 11133746 Free article.

3

FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia.

Stirewalt DL, Kopecky KJ, Meshinchi S, Appelbaum FR, Slovak ML, Willman CL, Radich JP. Stirewalt DL, et al. Among authors: meshinchi s. Blood. 2001 Jun 1;97(11):3589-95. doi: 10.1182/blood.v97.11.3589. Blood. 2001. PMID: 11369655 Free article.

4

Molecular targets in acute myelogenous leukemia.

Stirewalt DL, Meshinchi S, Radich JP. Stirewalt DL, et al. Among authors: meshinchi s. Blood Rev. 2003 Mar;17(1):15-23. doi: 10.1016/s0268-960x(02)00057-7. Blood Rev. 2003. PMID: 12490207 Review.

5

Activating mutations of RTK/ras signal transduction pathway in pediatric acute myeloid leukemia.

Meshinchi S, Stirewalt DL, Alonzo TA, Zhang Q, Sweetser DA, Woods WG, Bernstein ID, Arceci RJ, Radich JP. Meshinchi S, et al. Blood. 2003 Aug 15;102(4):1474-9. doi: 10.1182/blood-2003-01-0137. Epub 2003 Apr 17. Blood. 2003. PMID: 12702504 Free article.

6

Prognostic factors and risk-based therapy in pediatric acute myeloid leukemia.

Meshinchi S, Smith FO, Arceci RJ. Meshinchi S, et al. Curr Oncol Rep. 2003 Nov;5(6):489-97. doi: 10.1007/s11912-003-0010-1. Curr Oncol Rep. 2003. PMID: 14521808 Review.

7

Progenitor cell involvement is predictive of response to induction chemotherapy in paediatric acute myeloid leukaemia.

Johnston DL, Meshinchi S, Opheim KE, Pallavicini MG, Feusner J, Woods WG, Lange BJ, Radich JP, Bernstein ID. Johnston DL, et al. Among authors: meshinchi s. Br J Haematol. 2003 Nov;123(3):431-5. doi: 10.1046/j.1365-2141.2003.04633.x. Br J Haematol. 2003. PMID: 14617001 Free article.

8

Survival after second hematopoietic stem cell transplantation for recurrent pediatric acute myeloid leukemia.

Meshinchi S, Leisenring WM, Carpenter PA, Woolfrey AE, Sievers EL, Radich JP, Sanders JE. Meshinchi S, et al. Biol Blood Marrow Transplant. 2003 Nov;9(11):706-13. doi: 10.1016/j.bbmt.2003.08.003. Biol Blood Marrow Transplant. 2003. PMID: 14652854 Free article.

9

Novel FLT3 point mutations within exon 14 found in patients with acute myeloid leukaemia.

Stirewalt DL, Meshinchi S, Kussick SJ, Sheets KM, Pogosova-Agadjanyan E, Willman CL, Radich JP. Stirewalt DL, et al. Among authors: meshinchi s. Br J Haematol. 2004 Feb;124(4):481-4. doi: 10.1111/j.1365-2141.2004.04808.x. Br J Haematol. 2004. PMID: 14984498 Free article.

10

Pediatric AML primary samples with FLT3/ITD mutations are preferentially killed by FLT3 inhibition.

Brown P, Meshinchi S, Levis M, Alonzo TA, Gerbing R, Lange B, Arceci R, Small D. Brown P, et al. Among authors: meshinchi s. Blood. 2004 Sep 15;104(6):1841-9. doi: 10.1182/blood-2004-03-1034. Epub 2004 May 27. Blood. 2004. PMID: 15166029 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

259 results

Search Page

Filters